Dendritic cells direct circadian anti-tumor immune responses.

Wang, Chen; Barnoud, Coline; Cenerenti, Mara; Sun, Mengzhu; Caffa, Irene; Kizil, Burak; Bill, Ruben; Liu, Yuanlong; Pick, Robert; Garnier, Laure; Gkountidi, Olga A; Ince, Louise M; Holtkamp, Stephan; Fournier, Nadine; Michielin, Olivier; Speiser, Daniel E; Hugues, Stéphanie; Nencioni, Alessio; Pittet, Mikaël J; Jandus, Camilla; ... (2023). Dendritic cells direct circadian anti-tumor immune responses. Nature, 614(7946), pp. 136-143. Springer Nature 10.1038/s41586-022-05605-0

[img]
Preview
Text
s41586-022-05605-0_reference.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (11MB) | Preview

The process of cancer immunosurveillance is a mechanism of tumor suppression that can protect the host from cancer development throughout its lifetime1,2. Yet, it is unknown whether its effectiveness fluctuates over a single day. Here, we demonstrate that the initial time-of-day of tumor engraftment dictates ensuing tumor size across murine cancer models. Using immunodeficient mice and animals lacking lineage-specific circadian functions, we show that dendritic cells (DCs) and CD8+ T cells exert circadian anti-tumor functions that control melanoma volume. Specifically, we find that rhythmic trafficking of DCs to the tumor draining lymph node (dLN) governs a circadian response of tumor antigen-specific CD8+ T cells, which is dependent on circadian expression of the co-stimulatory molecule CD80. Consequently, cancer immunotherapy is more effective when synchronized with DC functions, shows circadian outcomes in mice and suggests similar effects in humans. These data demonstrate that circadian rhythms of anti-tumor immune components are not only critical for the control of tumor size but can also be exploited therapeutically.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Bill, Ruben

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1476-4687

Publisher:

Springer Nature

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

13 Jan 2023 15:12

Last Modified:

07 Jun 2023 00:25

Publisher DOI:

10.1038/s41586-022-05605-0

PubMed ID:

36470303

BORIS DOI:

10.48350/176997

URI:

https://boris.unibe.ch/id/eprint/176997

Actions (login required)

Edit item Edit item
Provide Feedback